Clearside Biomedical Inc. (CLSD)
0.93
0.02 (2.47%)
At close: Apr 02, 2025, 3:59 PM
0.95
1.68%
After-hours: Apr 02, 2025, 07:53 PM EDT
Clearside Biomedical Cash Flow Statement
Financials in USD. Fiscal year
is
January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
Net Income | -34.35M | -32.48M | -32.95M | 376K | -18.21M | -30.77M | -82.82M | -58.98M | -25.88M | -17.64M | -10.19M | -7.25M | -3.93M |
Depreciation & Amortization | 226K | 67K | 145K | 178K | 180K | 211K | 189K | 182K | 65K | 60K | 33K | 15K | 7K |
Stock-Based Compensation | 4.51M | 4.2M | 4.88M | 5.05M | 3.6M | 4.61M | 4.79M | 3.36M | 1.31M | 705K | 427K | 322K | 266K |
Other Working Capital | n/a | 106K | 122K | -4.47M | 1.12M | 4.28M | -560K | 3.95M | -134K | 2.74M | 228K | 72K | n/a |
Other Non-Cash Items | 4.92M | 9.36M | 3.32M | -998K | 188K | 230K | 266K | 211K | 439K | 156K | 100K | 6K | 748K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -52K | -748K | 181K | 65K | 75K | 277K | n/a | n/a |
Change in Working Capital | n/a | 720K | 11.24M | -15.34M | 1.12M | -1.3M | -874K | 3.95M | 1.29M | 2.74M | 228K | 72K | n/a |
Operating Cash Flow | -24.7M | -18.14M | -13.37M | -10.73M | -13.12M | -27.07M | -79.2M | -51.08M | -22.71M | -13.9M | -9.12M | -6.84M | -3.18M |
Capital Expenditures | n/a | -1.78M | -246K | n/a | -55K | -25K | -88K | -306K | -3K | -32K | -140K | -63K | -57K |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -660K | -20.12M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -16.91M | n/a | n/a | n/a | n/a | n/a | -80.14M | -48.12M | -54.48M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 16.91M | n/a | n/a | n/a | n/a | 32.95M | 76.47M | 68.54M | 5.71M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -638K | n/a | -528K | n/a | -55K | 32.95M | 660K | 20.12M | -360K | 4K | n/a | n/a | n/a |
Investing Cash Flow | -638K | -1.78M | -246K | n/a | -55K | 32.92M | -3.76M | 20.12M | -49.14M | -28K | -140K | -63K | -57K |
Debt Repayment | n/a | n/a | n/a | n/a | -4.35M | -5M | 1.7M | n/a | 1.53M | 5.98M | 2.88M | 125K | 150K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.44M | -1.25M | 30.77M | 499K | 258K | 52K | 515K | 305K | 31K | 14K | 5K | 10K | -1 |
Financial Cash Flow | 16.44M | 414K | 31.33M | 23.78M | 7.87M | 8.7M | 81.78M | 5.36M | 86.39M | 25.94M | 15.62M | 7.96M | 4.08M |
Net Cash Flow | -8.9M | -19.5M | 17.72M | 13.05M | -5.31M | 14.55M | -1.18M | -25.6M | 14.54M | 12.01M | 6.36M | 1.05M | 843K |
Free Cash Flow | -24.7M | -19.91M | -13.61M | -10.73M | -13.18M | -27.09M | -79.29M | -51.39M | -22.71M | -13.93M | -9.26M | -6.9M | -3.23M |